Skip to main content
. 2014 Feb 13;592(Pt 7):1493–1503. doi: 10.1113/jphysiol.2013.267039

Figure 5.

Figure 5

A, representative recordings of glial ESCs (BGC, first panel) and Purkinje neuron EPSCs (PN, second panel) before (grey trace) and 30 min after (black trace) addition of the GluA2-deficient AMPAR pore blocker NASP (50 μm). B, time course of NASP's effect on glial ESCs (squares), Purkinje neuron EPSC amplitude (filled circles) and EPSC decay time (open circles). Data are mean ± SEM from six cells.